These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 13792788)

  • 21. Efficacy of trifluoperazine on withdrawal in chronic schizophrenia.
    GWYNNE PH; HUNDZIAK M; KAVTSCHITSCH J; LEFTON M; PASAMANICK B
    J Nerv Ment Dis; 1962 May; 134():451-5. PubMed ID: 13903283
    [No Abstract]   [Full Text] [Related]  

  • 22. [On stelazine therapy of chronic schizophrenia].
    NADZHAROV RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1962; 62():740-5. PubMed ID: 14477819
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of thioridazine for intensive treatment of schizophrenics refractory to other tranquilizing drugs.
    HOLLISTER LE; TRAUB L; PRUSMACK JJ
    J Neuropsychiatr; 1960 Apr; 1():200-4. PubMed ID: 14402703
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison between trifluoperazine and carphenazine in chronically ill schizophrenic in-patients.
    CACIOPPO J; BABIKIAN H; MERLIS S
    Dis Nerv Syst; 1961 Feb; 22(2)Suppl():46-50. PubMed ID: 13689709
    [No Abstract]   [Full Text] [Related]  

  • 25. Carphenazine in the treatment of chronic schizophrenics.
    BARSA JA; SAUNDERS JC
    Am J Psychiatry; 1962 Aug; 119():169. PubMed ID: 13865331
    [No Abstract]   [Full Text] [Related]  

  • 26. A terminal double-blind trail of tri-fluoperazine ("stelazine") in chronic schizophrenia.
    WESTON FK; LOFTUS AP
    Med J Aust; 1961 May; 48(1)():776-80. PubMed ID: 13784630
    [No Abstract]   [Full Text] [Related]  

  • 27. Thioridazine (mellaril) in the treatment of chronic schizophrenics.
    BARSA JA; SAUNDERS JC
    Am J Psychiatry; 1960 May; 116():1028-9. PubMed ID: 13797143
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluphenazine in chronic refractory schizophrenics.
    STRATAS NE
    Am J Psychiatry; 1962 Jul; 119():72. PubMed ID: 13917660
    [No Abstract]   [Full Text] [Related]  

  • 29. [2 years of treatment of long-standing schizophrenics by a sulfamido-phenothiazine (RP-7843)].
    AZOURI E
    Ann Med Psychol (Paris); 1961 Nov; 119(2)():708-13. PubMed ID: 13863574
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of chlorpromazine with fluphenazine dihydrochloride in treatment of schizophrenics.
    SHAWVER JR; SCARBOROUGH JS; FRANK TV
    Dis Nerv Syst; 1962 Jul; 23():392-5. PubMed ID: 13911481
    [No Abstract]   [Full Text] [Related]  

  • 31. [Considerations on the therapeutic action of levomepromazine in a group of schizophrenics].
    D'ANGELO C; MATARAZZO F
    Gazz Med Ital; 1960 Apr; 119():140-2. PubMed ID: 13813573
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of thioproperazine in the treatment of schizophrenics and manic patients].
    NOMURA A; YORA T; SAKURAI Y; KONO A; KAWAJIRI T; MASHINO H; KAWAI H; OTA H
    No To Shinkei; 1961 Dec; 13():1019-24. PubMed ID: 14480260
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical evaluation of carphenazine and piperacetazine in previously placebo-treated chronic schizophrenics.
    CLAFFEY B; MARGOLIS LH; MANDEL W
    Am J Psychiatry; 1962 Jul; 119():75-6. PubMed ID: 13879634
    [No Abstract]   [Full Text] [Related]  

  • 34. Relevance of drug-induced extrapyramidal reactions to behavioral changes during neuroleptic treatment. II. Combined treatment with trifluoperazine-amobarbital.
    BRUNE GG; KOBAYASHI T; BULL C; TOURLENTES TT; HIMWICH HE
    Compr Psychiatry; 1962 Oct; 3():292-6. PubMed ID: 13873984
    [No Abstract]   [Full Text] [Related]  

  • 35. A controlled trial of thiopropazate dihydrochloride (dartalan). chlorpromazine and occupational therapy in chronic schizophrenics.
    HAMILTON M; SMITH AL; LAPIDUS HE; CADOGAN EP
    J Ment Sci; 1960 Jan; 106():40-55. PubMed ID: 14399273
    [No Abstract]   [Full Text] [Related]  

  • 36. The treatment of psychoneurotic conditions with trifluoperazine.
    BRAM G
    Br J Clin Pract; 1960 Feb; 14():107-9. PubMed ID: 13803809
    [No Abstract]   [Full Text] [Related]  

  • 37. WITHDRAWAL SYMPTOMS AFTER ABRUPT CESSATION OF ANTIPSYCHOTIC COMPOUNDS: CLINICAL CONFIRMATION IN CHRONIC SCHIZOPHRENICS.
    GALLANT DM; EDWARDS CG; BISHOP MP; GALBRAITH GC
    Am J Psychiatry; 1964 Nov; 121():491-3. PubMed ID: 14218408
    [No Abstract]   [Full Text] [Related]  

  • 38. [Contribution to the cases on trifluoperazine in psychiatric therapeutics].
    ACUSSE RUIZ G; NONINI J; BLASQUEZ S
    Sem Med; 1962 Jun; 120():1512-5. PubMed ID: 13859225
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of the clinical effects of carphenazine and fluphenazine in chronic schizophrenics.
    SAINZ A
    Dis Nerv Syst; 1961 Feb; 22(2)Suppl():77-9. PubMed ID: 13745447
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experiences with the use of thioridazine in a group of schizophrenics considered incurable].
    BARUCCI M; DE LUCA PL
    Rass Studi Psichiatr; 1960; 49():821-40. PubMed ID: 13687526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.